James H. Sabry, Director at CYTOKINETICS INC (CYTK), sold 49,100 shares at $2.85 ($139K) on 2009-08-20, disclosed to the SEC on 2009-08-21.
Open-market sale of $139k CYTK by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.80 | 7,348 | $21K | 14.8% |
| 2 | $2.81 | 3,337 | $9K | 6.7% |
| 3 | $2.82 | 7,570 | $21K | 15.4% |
| 4 | $2.83 | 5,388 | $15K | 11.0% |
| 5 | $2.84 | 5,457 | $15K | 11.1% |
| 6 | $2.82 | 173 |
| $488 |
| 0.4% |
| 7 | $2.83 | 6,507 | $18K | 13.2% |
| 8 | $2.84 | 700 | $2K | 1.4% |
| 9 | $2.85 | 3,600 | $10K | 7.4% |
| 10 | $2.86 | 2,959 | $8K | 6.1% |
| 11 | $2.87 | 5,075 | $15K | 10.5% |
| 12 | $2.88 | 986 | $3K | 2.0% |
| Total | $2.83 avg | 49,100 | $139K | 100% |
| Filing → |
| CYTK | SELL | 2010-05-14 | $30K | — | Filing → |
| CYTK | SELL | 2010-04-28 | $32K | — | Filing → |
| CYTK | SELL | 2010-04-01 | $32K | — | Filing → |